Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raymond Sawaya

Showing results (131-140 of 163) with videos related to

Pageof 17
Sort By:
Cancer Cell|October 22, 2011
FoxM1 promotes β-catenin nuclear localization and controls Wnt target-gene expression and glioma tumorigenesisNu Zhang, Ping Wei, Aihua Gong, et al.
Journal of Neurosurgery|August 10, 2010
Multiple craniotomies in the management of multifocal and multicentric glioblastoma. Clinical articleWael Hassaneen, Nicholas B Levine, Dima Suki, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|November 9, 2023
Subependymomas of the fourth ventricle: To operate or not to operate?Ali S Haider, Ian E McCutcheon, Chibawanye I Ene, et al.
Oncology|December 6, 2003
Anaplastic oligodendrogliomas: prognostic factors for tumor recurrence and survivalVinay K Puduvalli, Masood Hashmi, Leslie D McAllister, et al.
Neurosurgery|February 26, 2019
Perilesional Resection of Glioblastoma Is Independently Associated With Improved OutcomesWajd N Al-Holou, Tiffany R Hodges, Richard G Everson, et al.
Neuro-Oncology|December 6, 2013
IDH1 mutant malignant astrocytomas are more amenable to surgical resection and have a survival benefit associated with maximal surgical resectionJason Beiko, Dima Suki, Kenneth R Hess, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 11, 2009
Clinical Cancer Advances 2009: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical OncologyNicholas J Petrelli, Eric P Winer, Julie Brahmer, et al.
Journal of Neuro-Oncology|April 6, 2018
Multi-center study finds postoperative residual non-enhancing component of glioblastoma as a new determinant of patient outcomeAikaterini Kotrotsou, Ahmed Elakkad, Jia Sun, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 24, 2008
Clinical cancer advances 2008: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical OncologyEric Winer, Julie Gralow, Lisa Diller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 6, 2010
Immunologic escape after prolonged progression-free survival with epidermal growth factor receptor variant III peptide vaccination in patients with newly diagnosed glioblastomaJohn H Sampson, Amy B Heimberger, Gary E Archer, et al.
Pageof 17

Showing results (131-140 of 163) with videos related to

Sort By:
Pageof 17
Cancer Cell|October 22, 2011
FoxM1 promotes β-catenin nuclear localization and controls Wnt target-gene expression and glioma tumorigenesisNu Zhang, Ping Wei, Aihua Gong, et al.
Journal of Neurosurgery|August 10, 2010
Multiple craniotomies in the management of multifocal and multicentric glioblastoma. Clinical articleWael Hassaneen, Nicholas B Levine, Dima Suki, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|November 9, 2023
Subependymomas of the fourth ventricle: To operate or not to operate?Ali S Haider, Ian E McCutcheon, Chibawanye I Ene, et al.
Oncology|December 6, 2003
Anaplastic oligodendrogliomas: prognostic factors for tumor recurrence and survivalVinay K Puduvalli, Masood Hashmi, Leslie D McAllister, et al.
Neurosurgery|February 26, 2019
Perilesional Resection of Glioblastoma Is Independently Associated With Improved OutcomesWajd N Al-Holou, Tiffany R Hodges, Richard G Everson, et al.
Neuro-Oncology|December 6, 2013
IDH1 mutant malignant astrocytomas are more amenable to surgical resection and have a survival benefit associated with maximal surgical resectionJason Beiko, Dima Suki, Kenneth R Hess, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 11, 2009
Clinical Cancer Advances 2009: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical OncologyNicholas J Petrelli, Eric P Winer, Julie Brahmer, et al.
Journal of Neuro-Oncology|April 6, 2018
Multi-center study finds postoperative residual non-enhancing component of glioblastoma as a new determinant of patient outcomeAikaterini Kotrotsou, Ahmed Elakkad, Jia Sun, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 24, 2008
Clinical cancer advances 2008: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical OncologyEric Winer, Julie Gralow, Lisa Diller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 6, 2010
Immunologic escape after prolonged progression-free survival with epidermal growth factor receptor variant III peptide vaccination in patients with newly diagnosed glioblastomaJohn H Sampson, Amy B Heimberger, Gary E Archer, et al.
Pageof 17